CRISPR–Cas systems exploit viral DNA injection to establish and maintain adaptive immunity

Joshua W. Modell, Wenyan Jiang and Luciano A. Marraffini ()
Additional contact information
Joshua W. Modell: Laboratory of Bacteriology, The Rockefeller University
Wenyan Jiang: Laboratory of Bacteriology, The Rockefeller University
Luciano A. Marraffini: Laboratory of Bacteriology, The Rockefeller University

Nature, 2017, vol. 544, issue 7648, 101-104

Abstract: Analysis of spacer acquisition in Staphylococcus aureus reveals that type II CRISPR–Cas systems exploit viral DNA injection to ensure a successful CRISPR immune response.

Date: 2017
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://www.nature.com/articles/nature21719 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:544:y:2017:i:7648:d:10.1038_nature21719

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/nature21719

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().